200 related articles for article (PubMed ID: 10339508)
1. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience.
Wetzler M; Dodge RK; Mrózek K; Carroll AJ; Tantravahi R; Block AW; Pettenati MJ; Le Beau MM; Frankel SR; Stewart CC; Szatrowski TP; Schiffer CA; Larson RA; Bloomfield CD
Blood; 1999 Jun; 93(11):3983-93. PubMed ID: 10339508
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
Byrd JC; Mrózek K; Dodge RK; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Patil SR; Rao KW; Watson MS; Koduru PR; Moore JO; Stone RM; Mayer RJ; Feldman EJ; Davey FR; Schiffer CA; Larson RA; Bloomfield CD;
Blood; 2002 Dec; 100(13):4325-36. PubMed ID: 12393746
[TBL] [Abstract][Full Text] [Related]
4. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Visani G; Bernasconi P; Boni M; Castoldi GL; Ciolli S; Clavio M; Cox MC; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga PP; Petti MC; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S
Leukemia; 2001 Jun; 15(6):903-9. PubMed ID: 11417475
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3.
Fenaux P; Lai JL; Morel P; Nelken B; Taboureau O; Deminatti M; Bauters F
Hematol Oncol; 1989; 7(4):307-17. PubMed ID: 2737611
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
Westbrook CA; Hooberman AL; Spino C; Dodge RK; Larson RA; Davey F; Wurster-Hill DH; Sobol RE; Schiffer C; Bloomfield CD
Blood; 1992 Dec; 80(12):2983-90. PubMed ID: 1467514
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Thomas DA; Cortes J; Giles F; Pierce S; Albitar M; Estrov Z
Leuk Lymphoma; 2000 Jan; 36(3-4):263-73. PubMed ID: 10674898
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.
Ludwig WD; Rieder H; Bartram CR; Heinze B; Schwartz S; Gassmann W; Löffler H; Hossfeld D; Heil G; Handt S; Heyll A; Diedrich H; Fischer K; Weiss A; Völkers B; Aydemir U; Fonatsch C; Gökbuget N; Thiel E; Hoelzer D
Blood; 1998 Sep; 92(6):1898-909. PubMed ID: 9731046
[TBL] [Abstract][Full Text] [Related]
10. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
Larson RA; Dodge RK; Burns CP; Lee EJ; Stone RM; Schulman P; Duggan D; Davey FR; Sobol RE; Frankel SR
Blood; 1995 Apr; 85(8):2025-37. PubMed ID: 7718875
[TBL] [Abstract][Full Text] [Related]
11. The importance of cytogenetic studies in adult acute lymphocytic leukemia.
Walters R; Kantarjian HM; Keating MJ; Estey EH; Trujillo J; Cork A; McCredie KB; Freireich EJ
Am J Med; 1990 Nov; 89(5):579-87. PubMed ID: 2239977
[TBL] [Abstract][Full Text] [Related]
12. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in adult acute lymphocytic leukemia.
Wetzler M
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1237-49. PubMed ID: 11147221
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of chemotherapeutic results and prognostic factors of adult acute lymphoblastic leukemia].
Fu MW; Mi YC; Qiu LG; Yu WJ; Lin D; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):435-40. PubMed ID: 19035173
[TBL] [Abstract][Full Text] [Related]
15. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.
Wetzler M; Dodge RK; Mrózek K; Stewart CC; Carroll AJ; Tantravahi R; Vardiman JW; Larson RA; Bloomfield CD
Br J Haematol; 2004 Feb; 124(3):275-88. PubMed ID: 14717774
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.
Mi Y; Xue Y; Yu W; Liu S; Zhao Y; Meng Q; Bian S; Wang J
Leuk Lymphoma; 2008 Mar; 49(3):524-30. PubMed ID: 18297530
[TBL] [Abstract][Full Text] [Related]
17. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
20. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
